{"entity":{"type":"insider","cik":"0001586660","url":"/insider/0001586660","json_url":"/insider/0001586660.json","name":"Golumbeski George","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":5,"first":"2019-02-13","last":"2022-05-09","span_basis":"filed_date"},"name_variants":[{"name":"Golumbeski George","source":"filing","n_filings":5,"first_seen":"2019-02-13","last_seen":"2022-05-09"}],"transactions":[{"id":6303119,"accession":"0001562180-22-003898","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-22-003898","line_url":"/filing/0001562180-22-003898#line-1","is_derivative":false,"issuer_cik":"0001586660","issuer_name":"Sage Therapeutics, Inc.","issuer_ticker":"SAGE","issuer_name_source":null,"issuer_url":"/issuer/0001586660","owner_cik":"0001586660","owner_name":"Golumbeski George","owner_display_name":"Golumbeski George","owner_url":"/insider/0001586660","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8000.0,"shares_display":"8,000","price_per_share":31.4454,"price_display":"31.45","price_state":"stated","total_value":251563.2,"total_display":"251,563.20","total_whole":"251,563","shares_owned_after":8000.0,"shares_owned_after_display":"8,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-05","filed_date":"2022-05-09","scope":"insider"},{"id":6443285,"accession":"0000899243-22-015764","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-015764","line_url":"/filing/0000899243-22-015764#line-1","is_derivative":false,"issuer_cik":"0001586660","issuer_name":"Shattuck Labs, Inc.","issuer_ticker":"STTK","issuer_name_source":null,"issuer_url":"/issuer/0001586660","owner_cik":"0001586660","owner_name":"Golumbeski George","owner_display_name":"Golumbeski George","owner_url":"/insider/0001586660","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":28330.0,"shares_display":"28,330","price_per_share":3.63,"price_display":"3.63","price_state":"stated","total_value":102837.9,"total_display":"102,837.90","total_whole":"102,838","shares_owned_after":54613.0,"shares_owned_after_display":"54,613","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-26","filed_date":"2022-04-27","scope":"insider"},{"id":6166817,"accession":"0000899243-22-015609","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-015609","line_url":"/filing/0000899243-22-015609#line-2","is_derivative":false,"issuer_cik":"0001586660","issuer_name":"Shattuck Labs, Inc.","issuer_ticker":"STTK","issuer_name_source":null,"issuer_url":"/issuer/0001586660","owner_cik":"0001586660","owner_name":"Golumbeski George","owner_display_name":"Golumbeski George","owner_url":"/insider/0001586660","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":234.0,"shares_display":"234","price_per_share":3.67,"price_display":"3.67","price_state":"stated","total_value":858.78,"total_display":"858.78","total_whole":"859","shares_owned_after":26283.0,"shares_owned_after_display":"26,283","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-22","filed_date":"2022-04-26","scope":"insider"},{"id":6166814,"accession":"0000899243-22-015609","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-015609","line_url":"/filing/0000899243-22-015609#line-1","is_derivative":false,"issuer_cik":"0001586660","issuer_name":"Shattuck Labs, Inc.","issuer_ticker":"STTK","issuer_name_source":null,"issuer_url":"/issuer/0001586660","owner_cik":"0001586660","owner_name":"Golumbeski George","owner_display_name":"Golumbeski George","owner_url":"/insider/0001586660","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":26049.0,"shares_display":"26,049","price_per_share":3.69,"price_display":"3.69","price_state":"stated","total_value":96120.81,"total_display":"96,120.81","total_whole":"96,121","shares_owned_after":26049.0,"shares_owned_after_display":"26,049","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-21","filed_date":"2022-04-26","scope":"insider"},{"id":8622032,"accession":"0001177648-19-000028","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001177648-19-000028","line_url":"/filing/0001177648-19-000028#line-2","is_derivative":false,"issuer_cik":"0001177648","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001177648","owner_cik":"0001586660","owner_name":"Golumbeski George","owner_display_name":"Golumbeski George","owner_url":"/insider/0001586660","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9280.0,"shares_display":"9,280","price_per_share":103.6527,"price_display":"103.65","price_state":"stated","total_value":961897.056,"total_display":"961,897.06","total_whole":"961,897","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-04","filed_date":"2019-03-06","scope":"insider"},{"id":8133429,"accession":"0001177648-19-000005","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001177648-19-000005","line_url":"/filing/0001177648-19-000005#line-5","is_derivative":false,"issuer_cik":"0001177648","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001177648","owner_cik":"0001586660","owner_name":"Golumbeski George","owner_display_name":"Golumbeski George","owner_url":"/insider/0001586660","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11228.0,"shares_display":"11,228","price_per_share":90.0696,"price_display":"90.07","price_state":"stated","total_value":1011301.4688,"total_display":"1,011,301.47","total_whole":"1,011,301","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-12","filed_date":"2019-02-13","scope":"insider"},{"id":8133419,"accession":"0001177648-19-000005","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001177648-19-000005","line_url":"/filing/0001177648-19-000005#line-2","is_derivative":false,"issuer_cik":"0001177648","issuer_name":"ENANTA PHARMACEUTICALS INC","issuer_ticker":"ENTA","issuer_name_source":null,"issuer_url":"/issuer/0001177648","owner_cik":"0001586660","owner_name":"Golumbeski George","owner_display_name":"Golumbeski George","owner_url":"/insider/0001586660","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2272.0,"shares_display":"2,272","price_per_share":90.0317,"price_display":"90.03","price_state":"stated","total_value":204552.0224,"total_display":"204,552.02","total_whole":"204,552","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-11","filed_date":"2019-02-13","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":7,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":7},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001597553","name":"Sage Therapeutics, Inc.","url":"/issuer/0001597553","role":"Director","n_filings":1,"first_seen":"2022-05-09","last_seen":"2022-05-09"},{"type":"issuer","type_label":"ISSUER","cik":"0001680367","name":"Shattuck Labs, Inc.","url":"/issuer/0001680367","role":"Director","n_filings":2,"first_seen":"2022-04-26","last_seen":"2022-04-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001177648","name":"ENANTA PHARMACEUTICALS INC","url":"/issuer/0001177648","role":"Director","n_filings":2,"first_seen":"2019-02-13","last_seen":"2019-03-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001586660","retrieved_at":"2026-08-25T12:45:49+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}